FDA Import Refusal 799-8952873-4/10003/1 — SANDOZ CANADA INCORPORATED

SANDOZ CANADA INCORPORATED — FEI 3040451368

The FDA refused shipment 799-8952873-4/10003/1 from SANDOZ CANADA INCORPORATED (Canada) on December 22, 2025. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
December 22, 2025
Country
Canada
Product Category
Drugs and Biologics
Product Code
61PCY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
Charges
75